Franklin Resources
KBIO

Franklin Resources’s KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) KBIO Stock Holding History

Franklin Resources’s Portfolio KBIO Stock Details KBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-77,443
Closed -$2.74M – 1632
2013
Q4 		$2.74M Buy
77,443
+7,275
+10% +$244K ﹤0.01% 1225
2013
Q3 		$2.54M Buy
70,168
+33,571
+92% +$1.53M ﹤0.01% 1202
2013
Q2 		$1.66M Buy
+36,597
New +$1.66M ﹤0.01% 1226

Other funds holding KBIO

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Franklin Resources's KBIO Position: Q1 2014 in Review

Franklin Resources sold out of KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) (KBIO) in Q1 2014, closing a stake of 77,443 shares — an estimated $2.74M sold.

Franklin Resources first reported a position in KBIO in Q2 2013 and held it in 3 quarters. The position peaked at $2.74M in Q4 2013. 48 funds tracked by Wall St. Rank hold KBIO as of Q1 2014.

  • Franklin Resources reported no remaining KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position as of Q1 2014 after selling out during the quarter.
  • Franklin Resources sold 77,443 KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) shares in Q1 2014, an estimated $2.74M.
  • Franklin Resources first reported a position in KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) in Q2 2013 and held it in 3 quarters.
  • Franklin Resources's KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position peaked at $2.74M in Q4 2013.
  • 48 funds tracked by Wall St. Rank held KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) as of Q1 2014.

Based on Franklin Resources's 13F filing for Q1 2014, filed 13 May 2014.